Sanofi India Ltd vs Walpar Nutritions Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Sanofi India Ltd is ₹ 3402 as of 05 May 15:30 . The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00% The p/e ratio of Walpar Nutritions Ltd changed from 32.1 to 17.1 over 4 quarters. This represents a CAGR of -46.73% The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% The market cap of Walpar Nutritions Ltd changed from ₹ 12.26 crore to ₹ 39.72 crore over 4 quarters. This represents a CAGR of 223.98% The Revenue of Sanofi India Ltd is ₹ 578.9 crore as of Jun '24 .The Revenue of Walpar Nutritions Ltd is ₹ 0 crore as of Jun '24 . The EBITDA of Sanofi India Ltd is ₹ 178.5 crore as of Jun '24 .The EBITDA of Walpar Nutritions Ltd is ₹ 0 crore as of Jun '24 . The Net Profit of Sanofi India Ltd is ₹ 136.6 crore as of Jun '24 .The Net Profit of Walpar Nutritions Ltd is ₹ 0 crore as of Jun '24 . The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00% The dividend payout of Walpar Nutritions Ltd changed from 0 % to 0 % over 10 quarters. This represents a CAGR of 0.0% .

About Sanofi India Ltd

Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.

About Walpar Nutritions Ltd

Walpar Nutritions Limited was originally formed and registered as a Partnership Firm in the name and style of 'M/s Walpar Healthcare', pursuant to a Deed of Partnership dated November 16, 2009.
Subsequently, the Constitution of Partnership Firm were changed on March 9, 2015, August 15, 2017 and June 12, 2020 by admission and retirement of Partners. 'M/s.
Walpar Healthcare' was thereafter converted from a erstwhile Partnership Firm to a Public Limited Company as 'Walpar Nutritions Limited' and received a Certificate of Incorporation dated December 4, 2020 from the Central Registration Center, Ministry of Corporate Affairs.
The Company is primarily engaged in manufacturing, marketing and trading of Pharmaceuticals, Nutraceutical, Herbal and Ayurvedic commodities online and offline. The Company made a public issue of 12,00,000 Equity Shares of having Face Value of Rs.

FAQs for the comparison of Sanofi India Ltd and Walpar Nutritions Ltd

Which company has a larger market capitalization, Sanofi India Ltd or Walpar Nutritions Ltd?

Market cap of Sanofi India Ltd is 8,111 Cr while Market cap of Walpar Nutritions Ltd is 34 Cr

What are the key factors driving the stock performance of Sanofi India Ltd and Walpar Nutritions Ltd?

The stock performance of Sanofi India Ltd and Walpar Nutritions Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi India Ltd and Walpar Nutritions Ltd?

As of May 5, 2026, the Sanofi India Ltd stock price is INR ₹3522.25. On the other hand, Walpar Nutritions Ltd stock price is INR ₹37.0.

How do dividend payouts of Sanofi India Ltd and Walpar Nutritions Ltd compare?

To compare the dividend payouts of Sanofi India Ltd and Walpar Nutritions Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.